78 related articles for article (PubMed ID: 7528655)
1. [Effect of recombinant human stem cell factor (rhSCF) on self-renewal of stem/progenitor cells of human acute myelogenous leukemia].
Tang JS; Li CY; Wang BM
Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):259-62. PubMed ID: 7528655
[TBL] [Abstract][Full Text] [Related]
2. Changes in phenotype and proliferative potential of human acute myeloblastic leukemia cells in culture with stem cell factor.
Ikeda H; Kanakura Y; Furitsu T; Kitayama H; Sugahara H; Nishiura T; Karasuno T; Tomiyama Y; Yamatodani A; Kanayama Y
Exp Hematol; 1993 Dec; 21(13):1686-94. PubMed ID: 7694869
[TBL] [Abstract][Full Text] [Related]
3. Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia.
Inatomi Y; Toyama K; Clark SC; Shimizu K; Miyauchi J
Cancer Res; 1994 Jan; 54(2):455-62. PubMed ID: 7506123
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
6. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1.
DiGiuseppe JA; Kastan MB; Weng LJ; Gore SD
In Vivo; 1999; 13(1):1-6. PubMed ID: 10218124
[TBL] [Abstract][Full Text] [Related]
8. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
9. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
[TBL] [Abstract][Full Text] [Related]
10. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation by hematopoietic growth factors of apoptosis and mitosis in acute myeloblastic leukemia cells.
Murohashi I; Yoshida K; Handa A; Murayoshi M; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1997 Sep; 25(10):1042-50. PubMed ID: 9293901
[TBL] [Abstract][Full Text] [Related]
12. Paracrine and autocrine growth mechanisms of human stem cell factor (c-kit ligand) in myeloid leukemia.
Pietsch T
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):285-6. PubMed ID: 7687773
[TBL] [Abstract][Full Text] [Related]
13. Role of suramin as an IL-1 inhibitor in suppression of acute myelogenous leukemia progenitor proliferation.
Estrov Z; Talpaz M; Estey EH; Strassmann G
Exp Hematol; 1995 Sep; 23(10):1080-7. PubMed ID: 7544738
[TBL] [Abstract][Full Text] [Related]
14. Effects of stem cell factor (SCF) on the in vitro growth of leukemic blast progenitors in acute non-lymphocytic leukemia.
Nara N; Tanikawa S; Nagata K; Hamaguchi H; Tomiyama J
Int J Hematol; 1993 Aug; 58(1-2):27-35. PubMed ID: 7693028
[TBL] [Abstract][Full Text] [Related]
15. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression.
Goff JP; Shields DS; Petersen BE; Zajac VF; Michalopoulos GK; Greenberger JS
Stem Cells; 1996 Sep; 14(5):592-602. PubMed ID: 8888500
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product.
de Vos S; Brach MA; Asano Y; Ludwig WD; Bettelheim P; Gruss HJ; Herrmann F
Cancer Res; 1993 Aug; 53(15):3638-42. PubMed ID: 7687925
[TBL] [Abstract][Full Text] [Related]
19. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment].
Gotoh A; Kawanishi Y; Kurosawa K; Miyazawa K; Ohtaka M; Aizawa S; Kimura Y; Yoshikawa O; Toyama K
Rinsho Ketsueki; 1993 Jul; 34(7):821-8. PubMed ID: 7689660
[TBL] [Abstract][Full Text] [Related]
20. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia.
Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
